Real-time enrollment status for this advanced malignancies clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 1:41 PM UTC
| NCT Number | NCT07644039 |
| Recruiting Status | Recruiting |
| Condition | Advanced Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 119 participants |
| Active Locations | 6 sites in the US |
| Sponsor | PharmaMar |
| Last Updated on CT.gov | July 30, 2026 (4 weeks ago) |
As of August 28, 2026: Clinical trial NCT07644039 is currently recruiting participants. This phase1 study for advanced malignancies is actively seeking new participants at 6 locations across the United States. The study is sponsored by PharmaMar. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07644039 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07644039 was last updated 4 weeks ago (July 30, 2026). HelloStudys verifies this status automatically.